References
- 1. Elghetany TM, Bhatla T. Myelodysplastic Syndromes and Myeloproliferative Disorders. Lanzkowsky P. Hofmann I. Jeffrey M. Lipton Lanzkowsky’s Manual of Pediatric Hematology and Oncology. Sixth Edition Elsevier. 2016, London, 348-351.
- 2. Hasle H, Niemeyer CM, Chessells JM. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia. 2003;17(2):277-282. DOI: 10.1038/sj.leu.240276510.1038/sj.leu.2402765
- 3. Disperati P, Ichim CV, Tkachuk D. Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology. Leuk Res. 2006;30:233-239. DOI: 10.1016/j.leukres.2005.06.01110.1016/j.leukres.2005.06.011
- 4. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;1145(5):937-51. DOI: 10.1182/blood-2009-03-20926210.1182/blood-2009-03-209262
- 5. Tefferi A. Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol. 2005;23(33):8520-30. DOI: 10.1200/JCO.2004.00.9316 10.1200/JCO.2004.00.9316
- 6. Das P, Deepali J, Das R, Garewal G. Hyperfibrotic myelodysplastic syndrome: a report of three cases from north India. Turk J Hematol. 2009;26:93-6.
- 7. Bowen D, Culligan D, Jowitt S, Kelsey S, Mufti G, Oscier D, et al. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. Br J Haematol. 2003;120(2):187-200. DOI: 10.1046/j.1365-2141.2003.03907.x10.1046/j.1365-2141.2003.03907.x
- 8. Porwit A, Saft L. The AML-MDS interface-leukemic transformation in myelodysplastic syndromes. J Hematopathol. 2011;4:69-79. DOI: 10.1007/s12308-011-0088-6
- 9. Diem H. Myelodysplasia. Tehml H, Diem H, Haferlach T. Color Atlas of Hematology - Practical Microscopic and Clinical Diagnosis. 2nd revised edition 2004. Munich, 106-9.
- 10. Glaubach T, Robinson L.J, Corey S.J Pediatric Myelodysplastic Syndromes: They Do Exist! J Pediatr Hematol Oncol. 2014;36:1-7. DOI: 10.1097/MPH.0000000000000046
- 11. Elghetany TM. Myelodysplastic syndromes in children: a critical review of issues in the diagnosis and classification of 887 cases from 13 published series. Arch Pathol Lab Med. 2007;131:1110-6.
- 12. Cîrstea M, Coliță A, Ionescu B, Ghiaur A, Vasilescu D, et al. Therapy-related myelodysplastic syndrome after successful treatment of acute promyelocytic leukemia: case report and literature review. Rev Romana Med Lab. 2017;25(2):165-79. DOI: 10.1515/rrlm-2017-001310.1515/rrlm-2017-0013
- 13. Camitta BM. Diseases of blood: Splenomegaly. Kliegman RM. Behrman RE, Jenson HB, Waldo E, Nelson Textbook of Pediatrics. 18th edition, Philadelphia, Elsevier, 2008, 2091-2.
- 14. Leguit RJ, Van Den Tweel J.G. The pathology of bone marrow failure. Histopathology. 2010;57(5):655-670. DOI: 10.1111/j.1365-2559.2010.03612.x10.1111/j.1365-2559.2010.03612.x
- 15. Bănescu C, Benedek I, Duicu C, Demian S, Voidăzan S. Cytogenetic findings and their prognostic impact in myelodysplastic syndrome patients. Rev Romana MedLab. 2011;19(2):139-47.
- 16. Della Porta MG, Malcovati L. Myelodysplastic syndromes with bone marrow fibrosis, Haematol Hematol J. 2011;96:180-3. DOI: 10.3324/haematol.2010.03987510.3324/haematol.2010.039875
- 17. Geddes AD, Bowen DT, Jacobs A. Clonal karyotype abnormalities and clinical progress in the myelodysplastic syndrome, Br J Haematol. 1990;76(2):194-202. DOI: 10.1111/j.1365-2141.1990.tb07871.x10.1111/j.1365-2141.1990.tb07871.x
- 18. Bernasconi P, Klersy C, Boni M. Does cytogenetic evolution have may any prognostic relevance in myelodysplastic syndromes? Ann Hematol. 2010;89:545-551. DOI: 10.1007/s00277-010-0927-z10.1007/s00277-010-0927-z
- 19. Koppel A, Schiller G. Myelodysplastic syndrome: an update on diagnosis and therapy. Curr Oncol Rep. 2008 10(5):372-378. DOI: 10.1007/s11912-008-0058-z10.1007/s11912-008-0058-z
- 20. Xiaojun KS, Xu Min L. Hypocellular myelodysplastic syndrome with myelofibrosis in acute myeloid leukemia transformation: A case report. Oncol Lett. 2015;10:422-4.